Active Not Recruiting OBSERVATIONAL NCT06885619

Prediction of LVAR and MACE in AMI Though Plasma Multiomics Analysis

Prediction of Left Ventricular Adverse Remodeling and Major Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction Though Plasma Multiomics Analysis

Sponsor: Beijing Anzhen Hospital

Conditions Acute Myocardial Infarction (AMI) Left Ventricular Remodeling Major Adverse Cardiovascular Event Plasma Multi-Omics

Interventions Diagnostic Test: echocardiography and blood collection

Updated 2 times since 2025 Last updated: Jul 29, 2025 Started: Jan 1, 2025 Primary completion: Dec 31, 2027 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Acute Myocardial Infarction (AMI) and Left Ventricular Remodeling, this trial is ongoing. The trial is conducted by Beijing Anzhen Hospital and has accumulated 2 data snapshots since 2025. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

2 versions recorded

Aug 2025 — Present [monthly]

Active Not Recruiting
Apr 2025 — Aug 2025 [monthly]

Active Not Recruiting

First recorded

Jan 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Anzhen Hospital

Data source: Beijing Anzhen Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China